RS56896B1 - Kristalna faza (3s,3s') 4,4'-disulfandiilbis(3-aminobutan 1-sulfonske kiseline) sa l-lizinom - Google Patents
Kristalna faza (3s,3s') 4,4'-disulfandiilbis(3-aminobutan 1-sulfonske kiseline) sa l-lizinomInfo
- Publication number
- RS56896B1 RS56896B1 RS20180133A RSP20180133A RS56896B1 RS 56896 B1 RS56896 B1 RS 56896B1 RS 20180133 A RS20180133 A RS 20180133A RS P20180133 A RSP20180133 A RS P20180133A RS 56896 B1 RS56896 B1 RS 56896B1
- Authority
- RS
- Serbia
- Prior art keywords
- absd
- phase
- lysine
- crystalline form
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/26—Separation; Purification; Stabilisation; Use of additives
- C07C319/28—Separation; Purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306307.5A EP2722327A1 (en) | 2012-10-22 | 2012-10-22 | Crystalline phase of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) with L-lysine |
| EP13779603.3A EP2909169B1 (en) | 2012-10-22 | 2013-10-22 | Crystalline phase of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) with l-lysine |
| PCT/EP2013/072028 WO2014064077A1 (en) | 2012-10-22 | 2013-10-22 | Crystalline phase of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS56896B1 true RS56896B1 (sr) | 2018-04-30 |
Family
ID=47278723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20180133A RS56896B1 (sr) | 2012-10-22 | 2013-10-22 | Kristalna faza (3s,3s') 4,4'-disulfandiilbis(3-aminobutan 1-sulfonske kiseline) sa l-lizinom |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US9278921B2 (enExample) |
| EP (2) | EP2722327A1 (enExample) |
| JP (1) | JP6317358B2 (enExample) |
| KR (1) | KR102103407B1 (enExample) |
| CN (1) | CN104768927B (enExample) |
| AR (1) | AR093070A1 (enExample) |
| AU (1) | AU2013336738B2 (enExample) |
| BR (1) | BR112015008931B1 (enExample) |
| CA (1) | CA2884914C (enExample) |
| CY (1) | CY1119913T1 (enExample) |
| DK (1) | DK2909169T3 (enExample) |
| EA (1) | EA024460B1 (enExample) |
| ES (1) | ES2658413T3 (enExample) |
| HR (1) | HRP20180189T1 (enExample) |
| HU (1) | HUE036037T2 (enExample) |
| IL (1) | IL237733B (enExample) |
| IN (1) | IN2015DN02807A (enExample) |
| LT (1) | LT2909169T (enExample) |
| ME (1) | ME02955B (enExample) |
| MX (1) | MX353693B (enExample) |
| NO (1) | NO2909169T3 (enExample) |
| NZ (1) | NZ706070A (enExample) |
| PL (1) | PL2909169T3 (enExample) |
| PT (1) | PT2909169T (enExample) |
| RS (1) | RS56896B1 (enExample) |
| SI (1) | SI2909169T1 (enExample) |
| SM (1) | SMT201800086T1 (enExample) |
| TW (1) | TWI643842B (enExample) |
| WO (1) | WO2014064077A1 (enExample) |
| ZA (1) | ZA201503574B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103951562B (zh) * | 2014-05-09 | 2016-04-20 | 四川九章生物化工科技发展有限公司 | 一种绿原酸晶型及其制备方法 |
| WO2022225712A1 (en) * | 2021-04-22 | 2022-10-27 | Teva Pharmaceuticals International Gmbh | Solid state forms of firibastat and processes for preparation thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004007441A2 (fr) | 2002-07-16 | 2004-01-22 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Derives de 4,4' -dithiobis- (3-aminobutane-1-sulfonates) nouveaux et compositions les contenant |
| FR2858617A1 (fr) * | 2003-08-06 | 2005-02-11 | Inst Nat Sante Rech Med | Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant |
| TWI370818B (en) * | 2006-04-05 | 2012-08-21 | Astellas Pharma Inc | Cocrystal of c-glycoside derivative and l-proline |
| EP2439192A1 (en) | 2010-10-07 | 2012-04-11 | Quantum Genomics | Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) |
| WO2012138907A2 (en) * | 2011-04-05 | 2012-10-11 | Translational Genomics Research Institute | Solid forms of curcumin |
-
2012
- 2012-10-22 EP EP12306307.5A patent/EP2722327A1/en not_active Withdrawn
-
2013
- 2013-10-18 AR ARP130103795A patent/AR093070A1/es unknown
- 2013-10-22 ES ES13779603.3T patent/ES2658413T3/es active Active
- 2013-10-22 NZ NZ706070A patent/NZ706070A/en not_active IP Right Cessation
- 2013-10-22 US US14/437,343 patent/US9278921B2/en not_active Expired - Fee Related
- 2013-10-22 MX MX2015005059A patent/MX353693B/es active IP Right Grant
- 2013-10-22 SI SI201330952T patent/SI2909169T1/en unknown
- 2013-10-22 TW TW102138122A patent/TWI643842B/zh not_active IP Right Cessation
- 2013-10-22 JP JP2015537299A patent/JP6317358B2/ja not_active Expired - Fee Related
- 2013-10-22 AU AU2013336738A patent/AU2013336738B2/en not_active Ceased
- 2013-10-22 EP EP13779603.3A patent/EP2909169B1/en active Active
- 2013-10-22 KR KR1020157013661A patent/KR102103407B1/ko active Active
- 2013-10-22 CN CN201380052793.5A patent/CN104768927B/zh not_active Expired - Fee Related
- 2013-10-22 BR BR112015008931-3A patent/BR112015008931B1/pt not_active IP Right Cessation
- 2013-10-22 WO PCT/EP2013/072028 patent/WO2014064077A1/en not_active Ceased
- 2013-10-22 SM SM20180086T patent/SMT201800086T1/it unknown
- 2013-10-22 RS RS20180133A patent/RS56896B1/sr unknown
- 2013-10-22 PL PL13779603T patent/PL2909169T3/pl unknown
- 2013-10-22 HR HRP20180189TT patent/HRP20180189T1/hr unknown
- 2013-10-22 EA EA201500438A patent/EA024460B1/ru unknown
- 2013-10-22 HU HUE13779603A patent/HUE036037T2/hu unknown
- 2013-10-22 ME MEP-2018-29A patent/ME02955B/me unknown
- 2013-10-22 CA CA2884914A patent/CA2884914C/en active Active
- 2013-10-22 LT LTEP13779603.3T patent/LT2909169T/lt unknown
- 2013-10-22 IN IN2807DEN2015 patent/IN2015DN02807A/en unknown
- 2013-10-22 PT PT137796033T patent/PT2909169T/pt unknown
- 2013-10-22 DK DK13779603.3T patent/DK2909169T3/en active
- 2013-10-22 NO NO13779603A patent/NO2909169T3/no unknown
-
2015
- 2015-03-12 IL IL237733A patent/IL237733B/en active IP Right Grant
- 2015-05-21 ZA ZA2015/03574A patent/ZA201503574B/en unknown
-
2016
- 2016-02-01 US US15/012,625 patent/US9487477B2/en not_active Expired - Fee Related
-
2018
- 2018-02-14 CY CY20181100179T patent/CY1119913T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3263100B1 (en) | L-ornithine phenyl acetate and methods of making thereof | |
| AU2015221466B2 (en) | L-ornithine phenyl acetate and methods of making thereof | |
| RS56896B1 (sr) | Kristalna faza (3s,3s') 4,4'-disulfandiilbis(3-aminobutan 1-sulfonske kiseline) sa l-lizinom | |
| HK1212321B (en) | Crystalline phase of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine | |
| CA3218617A1 (en) | Novel forms of entinostat | |
| HK40033714B (en) | L-ornithine phenyl acetate and methods of making thereof | |
| HK1248558B (en) | L-ornithine phenyl acetate and methods of making thereof | |
| WO2008031184A1 (en) | Creatine pyroglutamic acid salts and methods for their production and use in individuals | |
| HK1166699A (en) | L-ornithine phenyl acetate and methods of making thereof | |
| HK1166699B (en) | L-ornithine phenyl acetate and methods of making thereof | |
| HK1149744B (en) | Crystalline modifications of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl -propyl)-phenol |